{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:16:03Z","timestamp":1790136963312,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2018YFC1004604"],"award-info":[{"award-number":["2018YFC1004604"]}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02267"],"award-info":[{"award-number":["2018-02267"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Science and Technology of Henan Province of China","award":["134200510023"],"award-info":[{"award-number":["134200510023"]}]},{"name":"Department of Science and Technology of Henan Province of China","award":["171100310200"],"award-info":[{"award-number":["171100310200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Necrotizing enterocolitis (NEC) is one of the most severe complications in very preterm infants, but there are currently no accepted methods to prevent NEC. Studies have shown that erythropoietin (EPO) has the potential to prevent NEC or improve outcomes of preterm NEC. This study aimed to determine whether recombinant human EPO (rhEPO) could protect against NEC in very preterm infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study was a prospective randomized clinical trial performed among four NICU centers. A total of 1327 preterm infants with gestational age \u2264\u200932\u00a0weeks were admitted to the centers, and 42 infants were excluded leaving 1285 eligible infants to be randomized to the rhEPO or control group. Infants in the rhEPO group were given 500\u00a0IU\/kg rhEPO intravenously every other day for 2\u00a0weeks, while the control group was given the same volume of saline. The primary outcome was the incidence of NEC in very preterm infants at 36\u00a0weeks of corrected gestational age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1285 infants were analyzed at 36\u00a0weeks of corrected age for the incidence of NEC. rhEPO treatment significantly decreased the incidence of NEC (stage I, II and III) (12.0% vs. 17.1%,\n                      <jats:italic>p\u2009<\/jats:italic>\n                      =\u20090.010), especially confirmed NEC (stage II and III) (3.0% vs. 5.4%,\n                      <jats:italic>p\u2009<\/jats:italic>\n                      =\u20090.027). Meanwhile, rhEPO treatment significantly reduced the number of red blood cells transfusion in the confirmed NEC cases (1.2\u2009\u00b1\u20090.4 vs. 2.7\u2009\u00b1\u20091.0,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004). Subgroup analyses showed that rhEPO treatment significantly decreased the incidence of confirmed NEC at gestational age\u2009&lt;\u200928\u00a0weeks (\n                      <jats:italic>p\u2009<\/jats:italic>\n                      =\u20090.019), and the incidence of all stages NEC in preterm infants with hemoglobin &lt;\u200990\u00a0g\/l (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.000) and 5\u00a0min Apgar score &gt;\u20095 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Repeated low-dose rhEPO treatment is beneficial against NEC in very preterm infants.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      The protocol was registered retrospectively at ClinicalTrials.gov (NCT03919500) on April 18, 2019.\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03919500\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03919500<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-020-02459-w","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T05:02:52Z","timestamp":1596862972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Erythropoietin prevents necrotizing enterocolitis in very preterm infants: a randomized controlled trial"],"prefix":"10.1186","volume":"18","clinical-trial-number":[{"clinical-trial-number":"nct03919500","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xirui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5029-6730","authenticated-orcid":false,"given":"Changlian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,8]]},"reference":[{"issue":"2","key":"2459_CR1","doi-asserted-by":"crossref","first-page":"F182","DOI":"10.1136\/archdischild-2017-313880","volume":"103","author":"C Battersby","year":"2018","unstructured":"Battersby C, Santhalingam T, Costeloe K, Modi N. Incidence of neonatal necrotising enterocolitis in high-income countries: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2018;103(2):F182\u20139.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"2459_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/jamapediatrics.2014.2085","volume":"169","author":"ZJ Kastenberg","year":"2015","unstructured":"Kastenberg ZJ, Lee HC, Profit J, Gould JB, Sylvester KG. Effect of deregionalized care on mortality in very low-birth-weight infants with necrotizing enterocolitis. JAMA Pediatr. 2015;169(1):26\u201332.","journal-title":"JAMA Pediatr"},{"issue":"3","key":"2459_CR3","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1542\/peds.2004-0569","volume":"115","author":"SR Hintz","year":"2005","unstructured":"Hintz SR, Kendrick DE, Stoll BJ, Vohr BR, Fanaroff AA, Donovan EF, et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics. 2005;115(3):696\u2013703.","journal-title":"Pediatrics"},{"issue":"12","key":"2459_CR4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/jamapediatrics.2016.1936","volume":"170","author":"S Chawla","year":"2016","unstructured":"Chawla S, Natarajan G, Shankaran S, Pappas A, Stoll BJ, Carlo WA, et al. Association of neurodevelopmental outcomes and neonatal morbidities of extremely premature infants with differential exposure to antenatal steroids. JAMA Pediatr. 2016;170(12):1164\u201372.","journal-title":"JAMA Pediatr"},{"issue":"6","key":"2459_CR5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/gutjnl-2016-312819","volume":"67","author":"CA Autran","year":"2018","unstructured":"Autran CA, Kellman BP, Kim JH, Asztalos E, Blood AB, Spence ECH, et al. Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants. Gut. 2018;67(6):1064\u201370.","journal-title":"Gut"},{"issue":"10019","key":"2459_CR6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(15)01027-2","volume":"387","author":"K Costeloe","year":"2016","unstructured":"Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet (London, England). 2016;387(10019):649\u201360.","journal-title":"Lancet (London, England)."},{"key":"2459_CR7","first-page":"Cd007137","volume":"6","author":"M Pammi","year":"2017","unstructured":"Pammi M, Suresh G. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2017;6:Cd007137.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2459_CR8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.clp.2015.04.004","volume":"42","author":"SE Juul","year":"2015","unstructured":"Juul SE, Pet GC. Erythropoietin and neonatal neuroprotection. Clin Perinatol. 2015;42(3):469\u201381.","journal-title":"Clin Perinatol"},{"issue":"4","key":"2459_CR9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000073642","volume":"84","author":"A Kumral","year":"2003","unstructured":"Kumral A, Baskin H, Duman N, Yilmaz O, Tatli M, Ozer E, et al. Erythropoietin protects against necrotizing enterocolitis of newborn rats by the inhibiting nitric oxide formation. Biol Neonate. 2003;84(4):325\u20139.","journal-title":"Biol Neonate"},{"issue":"14","key":"2459_CR10","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1074\/jbc.M110.154625","volume":"286","author":"SR Shiou","year":"2011","unstructured":"Shiou SR, Yu Y, Chen S, Ciancio MJ, Petrof EO, Sun J, et al. Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis. J Biol Chem. 2011;286(14):12123\u201332.","journal-title":"J Biol Chem"},{"issue":"7","key":"2459_CR11","doi-asserted-by":"crossref","first-page":"e69620","DOI":"10.1371\/journal.pone.0069620","volume":"8","author":"Y Yu","year":"2013","unstructured":"Yu Y, Shiou SR, Guo Y, Lu L, Westerhoff M, Sun J, et al. Erythropoietin protects epithelial cells from excessive autophagy and apoptosis in experimental neonatal necrotizing enterocolitis. PLoS ONE. 2013;8(7):e69620.","journal-title":"PLoS ONE"},{"issue":"2","key":"2459_CR12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0022-3468(00)90006-X","volume":"35","author":"DJ Ledbetter","year":"2000","unstructured":"Ledbetter DJ, Juul SE. Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg. 2000;35(2):178\u201382.","journal-title":"J Pediatr Surg"},{"issue":"6","key":"2459_CR13","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3892\/etm.2016.3199","volume":"11","author":"W Qi","year":"2016","unstructured":"Qi W, Shen Q, Zhang L, Han LP, Wang S. Study on the inflammatory intervention of erythropoietin on NEC. Exp Ther Med. 2016;11(6):2221\u20134.","journal-title":"Exp Ther Med"},{"issue":"6","key":"2459_CR14","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jpeds.2014.07.034","volume":"165","author":"MM El-Ganzoury","year":"2014","unstructured":"El-Ganzoury MM, Awad HA, El-Farrash RA, El-Gammasy TM, Ismail EA, Mohamed HE, et al. Enteral granulocyte-colony stimulating factor and erythropoietin early in life improves feeding tolerance in preterm infants: a randomized controlled trial. J Pediatr. 2014;165(6):1140\u20131145.e1.","journal-title":"J Pediatr"},{"issue":"2","key":"2459_CR15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/pr.2013.213","volume":"75","author":"MR Rosebraugh","year":"2014","unstructured":"Rosebraugh MR, Widness JA, Nalbant D, Cress G, Veng-Pedersen P. Pharmacodynamically optimized erythropoietin treatment combined with phlebotomy reduction predicted to eliminate blood transfusions in selected preterm infants. Pediatr Res. 2014;75(2):336\u201342.","journal-title":"Pediatr Res"},{"key":"2459_CR16","doi-asserted-by":"crossref","first-page":"105013","DOI":"10.1016\/j.ejps.2019.105013","volume":"138","author":"R D\u2019Cunha","year":"2019","unstructured":"D\u2019Cunha R, Schmidt R, Widness JA, Mock DM, Yan X, Cress GA, et al. Target-mediated disposition population pharmacokinetics model of erythropoietin in premature neonates following multiple intravenous and subcutaneous dosing regimens. Eur J Pharm Sci. 2019;138:105013.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"2459_CR17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1542\/peds.2007-2711","volume":"122","author":"SE Juul","year":"2008","unstructured":"Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE. A phase I\/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics. 2008;122(2):383\u201391.","journal-title":"Pediatrics"},{"issue":"1","key":"2459_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ana.24677","volume":"80","author":"J Song","year":"2016","unstructured":"Song J, Sun H, Xu F, Kang W, Gao L, Guo J, et al. Recombinant human erythropoietin improves neurological outcomes in very preterm infants. Ann Neurol. 2016;80(1):24\u201334.","journal-title":"Ann Neurol"},{"issue":"4","key":"2459_CR19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/pch\/19.4.213","volume":"19","author":"RK Whyte","year":"2014","unstructured":"Whyte RK, Jefferies AL, Newborn C, Canadian Paediatric Society F. Red blood cell transfusion in newborn infants. Paediatr Child Health. 2014;19(4):213\u201322.","journal-title":"Paediatr Child Health."},{"issue":"2","key":"2459_CR20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/jp.2008.141","volume":"29","author":"SE Wiedmeier","year":"2009","unstructured":"Wiedmeier SE, Henry E, Sola-Visner MC, Christensen RD. Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system. J Perinatol. 2009;29(2):130\u20136.","journal-title":"J Perinatol"},{"issue":"1","key":"2459_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","volume":"187","author":"MJ Bell","year":"1978","unstructured":"Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1\u20137.","journal-title":"Ann Surg"},{"issue":"3","key":"2459_CR22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/jp.2011.61","volume":"32","author":"DK Lambert","year":"2012","unstructured":"Lambert DK, Christensen RD, Baer VL, Henry E, Gordon PV, Besner GE, et al. Fulminant necrotizing enterocolitis in a multihospital healthcare system. J Perinatol. 2012;32(3):194\u20138.","journal-title":"J Perinatol"},{"issue":"1","key":"2459_CR23","doi-asserted-by":"crossref","first-page":"F5","DOI":"10.1136\/archdischild-2011-300435","volume":"98","author":"LA Fernandez-Carrocera","year":"2013","unstructured":"Fernandez-Carrocera LA, Solis-Herrera A, Cabanillas-Ayon M, Gallardo-Sarmiento RB, Garcia-Perez CS, Montano-Rodriguez R, et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500\u00a0g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2013;98(1):F5\u20139.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"2459_CR24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s004310100749","volume":"160","author":"D Boccia","year":"2001","unstructured":"Boccia D, Stolfi I, Lana S, Moro ML. Nosocomial necrotising enterocolitis outbreaks: epidemiology and control measures. Eur J Pediatr. 2001;160(6):385\u201391.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"2459_CR25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jpeds.2008.11.002","volume":"154","author":"J Meinzen-Derr","year":"2009","unstructured":"Meinzen-Derr J, Morrow AL, Hornung RW, Donovan EF, Dietrich KN, Succop PA. Epidemiology of necrotizing enterocolitis temporal clustering in two neonatology practices. J Pediatr. 2009;154(5):656\u201361.","journal-title":"J Pediatr"},{"issue":"3","key":"2459_CR26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1203\/00006450-199909000-00003","volume":"46","author":"SE Juul","year":"1999","unstructured":"Juul SE, Joyce AE, Zhao Y, Ledbetter DJ. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res. 1999;46(3):263\u20138.","journal-title":"Pediatr Res"},{"issue":"3","key":"2459_CR27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-3782(98)00030-9","volume":"52","author":"SE Juul","year":"1998","unstructured":"Juul SE, Yachnis AT, Christensen RD. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Human Dev. 1998;52(3):235\u201349.","journal-title":"Early Human Dev"},{"issue":"3","key":"2459_CR28","doi-asserted-by":"crossref","first-page":"e17776","DOI":"10.1371\/journal.pone.0017776","volume":"6","author":"N Nanthakumar","year":"2011","unstructured":"Nanthakumar N, Meng D, Goldstein AM, Zhu W, Lu L, Uauy R, et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS ONE. 2011;6(3):e17776.","journal-title":"PLoS ONE"},{"issue":"3","key":"2459_CR29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/aogs.12553","volume":"94","author":"L Seikku","year":"2015","unstructured":"Seikku L, Rahkonen L, Tikkanen M, Hamalainen E, Rahkonen P, Andersson S, et al. Amniotic fluid erythropoietin and neonatal outcome in pregnancies complicated by intrauterine growth restriction before 34 gestational weeks. Acta Obstet Gynecol Scand. 2015;94(3):288\u201394.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"2459_CR30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jpeds.2015.02.052","volume":"167","author":"JC Fauchere","year":"2015","unstructured":"Fauchere JC, Koller BM, Tschopp A, Dame C, Ruegger C, Bucher HU. Safety of early high-dose recombinant erythropoietin for neuroprotection in very preterm infants. J Pediatr. 2015;167(1):52\u201357.e1-3.","journal-title":"J Pediatr"},{"issue":"3","key":"2459_CR31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-2001-15485","volume":"11","author":"M Akisu","year":"2001","unstructured":"Akisu M, Kullahcioglu Girgin F, Baka M, Husseyinov A, Kultursay N. The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis. Eur J Pediatr Surg Zeitschrift fur Kinderchirurgie. 2001;11(3):167\u201372.","journal-title":"Eur J Pediatr Surg Zeitschrift fur Kinderchirurgie."},{"issue":"5","key":"2459_CR32","doi-asserted-by":"crossref","first-page":"F458","DOI":"10.1136\/archdischild-2015-309127","volume":"101","author":"M Holm","year":"2016","unstructured":"Holm M, Skranes J, Dammann O, Fichorova RN, Allred EN, Leviton A. Systemic endogenous erythropoietin and associated disorders in extremely preterm newborns. Arch Dis Child Fetal Neonatal Ed. 2016;101(5):F458\u201363.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"2459_CR33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/pr.2017.15","volume":"81","author":"A Frymoyer","year":"2017","unstructured":"Frymoyer A, Juul SE, Massaro AN, Bammler TK, Wu YW. High-dose erythropoietin population pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. Pediatr Res. 2017;81(6):865\u201372.","journal-title":"Pediatr Res"},{"issue":"4","key":"2459_CR34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMoa1403489","volume":"372","author":"RM Patel","year":"2015","unstructured":"Patel RM, Kandefer S, Walsh MC, Bell EF, Carlo WA, Laptook AR, et al. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med. 2015;372(4):331\u201340.","journal-title":"N Engl J Med"},{"issue":"9","key":"2459_CR35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jama.2016.1204","volume":"315","author":"RM Patel","year":"2016","unstructured":"Patel RM, Knezevic A, Shenvi N, Hinkes M, Keene S, Roback JD, et al. Association of red blood cell transfusion, anemia, and necrotizing enterocolitis in very low-birth-weight infants. JAMA. 2016;315(9):889\u201397.","journal-title":"JAMA"},{"issue":"3","key":"2459_CR36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/jp.2010.145","volume":"31","author":"R Singh","year":"2011","unstructured":"Singh R, Visintainer PF, Frantz ID 3rd, Shah BL, Meyer KM, Favila SA, et al. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. J Perinatol. 2011;31(3):176\u201382.","journal-title":"J Perinatol"},{"issue":"4","key":"2459_CR37","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/trf.15254","volume":"59","author":"CM Arthur","year":"2019","unstructured":"Arthur CM, Nalbant D, Feldman HA, Saeedi BJ, Matthews J, Robinson BS, et al. Anemia induces gut inflammation and injury in an animal model of preterm infants. Transfusion. 2019;59(4):1233\u201345.","journal-title":"Transfusion."},{"issue":"1","key":"2459_CR38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12887-018-1241-5","volume":"18","author":"T Marin","year":"2018","unstructured":"Marin T, Patel RM, Roback JD, Stowell SR, Guo Y, Easley K, et al. Does red blood cell irradiation and\/or anemia trigger intestinal injury in premature infants with birth weight\u2009<\/=\u20091250\u00a0g? An observational birth cohort study. BMC Pediatr. 2018;18(1):270.","journal-title":"BMC Pediatr."},{"issue":"3","key":"2459_CR39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/trf.15112","volume":"59","author":"RM Patel","year":"2019","unstructured":"Patel RM, Josephson CD, Shenvi N, Maheshwari A, Easley KA, Stowell S, et al. Platelet transfusions and mortality in necrotizing enterocolitis. Transfusion. 2019;59(3):981\u20138.","journal-title":"Transfusion."},{"issue":"1","key":"2459_CR40","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1038\/s41467-019-11199-5","volume":"10","author":"K MohanKumar","year":"2019","unstructured":"MohanKumar K, Namachivayam K, Song T, Jake Cha B, Slate A, Hendrickson JE, et al. A murine neonatal model of necrotizing enterocolitis caused by anemia and red blood cell transfusions. Nat Commun. 2019;10(1):3494.","journal-title":"Nat Commun."},{"issue":"5","key":"2459_CR41","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/14767058.2015.1016422","volume":"29","author":"BG Sood","year":"2016","unstructured":"Sood BG, Rambhatla A, Thomas R, Chen X. Decreased hazard of necrotizing enterocolitis in preterm neonates receiving red cell transfusions. J Matern Fetal Neonatal Med. 2016;29(5):737\u201344.","journal-title":"J Matern Fetal Neonatal Med."},{"issue":"6","key":"2459_CR42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1515\/jpm-2017-0048","volume":"46","author":"SE Rai","year":"2018","unstructured":"Rai SE, Sidhu AK, Krishnan RJ. Transfusion-associated necrotizing enterocolitis re-evaluated: a systematic review and meta-analysis. J Perinat Med. 2018;46(6):665\u201376.","journal-title":"J Perinat Med"},{"issue":"3","key":"2459_CR43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1542\/peds.2011-2872","volume":"129","author":"A Mohamed","year":"2012","unstructured":"Mohamed A, Shah PS. Transfusion associated necrotizing enterocolitis: a meta-analysis of observational data. Pediatrics. 2012;129(3):529\u201340.","journal-title":"Pediatrics"},{"issue":"3","key":"2459_CR44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jpeds.2010.09.015","volume":"158","author":"J Blau","year":"2011","unstructured":"Blau J, Calo JM, Dozor D, Sutton M, Alpan G, La Gamma EF. Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr. 2011;158(3):403\u20139.","journal-title":"J Pediatr"},{"issue":"6","key":"2459_CR45","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3109\/15513819409037698","volume":"14","author":"MS Caplan","year":"1994","unstructured":"Caplan MS, Hedlund E, Adler L, Hsueh W. Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis. Pediatric pathology. 1994;14(6):1017\u201328.","journal-title":"Pediatric pathology."},{"issue":"9","key":"2459_CR46","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00383-016-3940-z","volume":"32","author":"M Yamoto","year":"2016","unstructured":"Yamoto M, Nakazawa Y, Fukumoto K, Miyake H, Nakajima H, Sekioka A, et al. Risk factors and prevention for surgical intestinal disorders in extremely low birth weight infants. Pediatr Surg Int. 2016;32(9):887\u201393.","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"2459_CR47","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1542\/peds.2011-2022","volume":"129","author":"WH Yee","year":"2012","unstructured":"Yee WH, Soraisham AS, Shah VS, Aziz K, Yoon W, Lee SK. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics. 2012;129(2):e298\u2013304.","journal-title":"Pediatrics"},{"issue":"3","key":"2459_CR48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","volume":"382","author":"SE Juul","year":"2020","unstructured":"Juul SE, Comstock BA, Wadhawan R, Mayock DE, Courtney SE, Robinson T, et al. A randomized trial of erythropoietin for neuroprotection in preterm infants. N Engl J Med. 2020;382(3):233\u201343.","journal-title":"N Engl J Med"},{"issue":"6","key":"2459_CR49","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1542\/peds.2013-4307","volume":"133","author":"RK Ohls","year":"2014","unstructured":"Ohls RK, Kamath-Rayne BD, Christensen RD, Wiedmeier SE, Rosenberg A, Fuller J, et al. Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo. Pediatrics. 2014;133(6):1023\u201330.","journal-title":"Pediatrics"},{"issue":"4","key":"2459_CR50","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2008-2701","volume":"124","author":"MS Brown","year":"2009","unstructured":"Brown MS, Eichorst D, Lala-Black B, Gonzalez R. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics. 2009;124(4):e681\u20137.","journal-title":"Pediatrics"},{"key":"2459_CR51","first-page":"65","volume":"2","author":"SM Aher","year":"2020","unstructured":"Aher SM, Ohlsson A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev. 2020;2:65.","journal-title":"Cochrane Database Syst Rev"},{"key":"2459_CR52","doi-asserted-by":"crossref","first-page":"104831","DOI":"10.1016\/j.earlhumdev.2019.104831","volume":"137","author":"KCT Bui","year":"2019","unstructured":"Bui KCT, Kim R, Abbasi A, Nguyen M, Villosis MF, Chen Q. Erythropoietin treatment is associated with a reduction in moderate to severe bronchopulmonary dysplasia in preterm infants. A regional retrospective study. Early Human Dev. 2019;137:104831.","journal-title":"Early Human Dev."},{"issue":"8","key":"2459_CR53","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.2014.9645","volume":"312","author":"RH Leuchter","year":"2014","unstructured":"Leuchter RH, Gui L, Poncet A, Hagmann C, Lodygensky GA, Martin E, et al. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age. JAMA. 2014;312(8):817\u201324.","journal-title":"JAMA"},{"issue":"6","key":"2459_CR54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.siny.2018.07.006","volume":"23","author":"PC Ng","year":"2018","unstructured":"Ng PC. An update on biomarkers of necrotizing enterocolitis. Semin Fetal Neonatal Med. 2018;23(6):380\u20136.","journal-title":"Semin Fetal Neonatal Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02459-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-020-02459-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02459-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T09:12:54Z","timestamp":1696497174000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02459-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,8]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2459"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02459-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,8]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was approved by the Ethics Committee of Zhengzhou University and Henan Medical Academy (201201002).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"308"}}